FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Hospira KETOROLAC Tromethamine Inj Recall

KETOROLAC Tromethamine Inj

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jul 22, 2015
Recall ID
D-1242-2015
Check your lot numberHow we source this data

Summary

Hospira recalled KETOROLAC Tromethamine Inj starting Jun 30, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1242-2015 on Jul 22, 2015. Reason: Crystallization; identified as calcium salt of Ketorolac. Status: Ongoing.

Why it was recalled

Crystallization; identified as calcium salt of Ketorolac

Product description

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Lot numbers, UPCs & expiration codes

31075DK, 31076DK, EXP01JUL2015; 32345DK, 32368DK, EXP 01AUG2015; 33152DK, EXP 01SEP2015; 34538DK, EXP 01OCT2015; 37227DK, EXP 01JAN2016, 41525DK, 42255DK, EXP 01MAY2016; 46042DK, 46045DK, 46048DK, 46304DK, 46305DK, 46432DK, 46433DK, EXP 01OCT2016 AND NOVAPLUS LOT 31074DK, EXP 01JUL2015

Where it was sold

Nationwide, Puerto Rico, Guam, Canada and Singapore

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1242-2015
Classification
Class II
Status
Ongoing
Recall initiated
Jun 30, 2015
FDA report date
Jul 22, 2015
Quantity
5,214,900 vials (Hospira label); 250,600 vials (NOVAPLUS label)
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1242-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Ongoing
Country
United States
Event ID
71681
Address
600 N Field Dr
Code information
31075DK, 31076DK, EXP01JUL2015; 32345DK, 32368DK, EXP 01AUG2015; 33152DK, EXP 01SEP2015; 34538DK, EXP 01OCT2015; 37227DK, EXP 01JAN2016, 41525DK, 42255DK, EXP 01MAY2016; 46042DK, 46045DK, 46048DK, 46304DK, 46305DK, 46432DK, 46433DK, EXP 01OCT2016 AND NOVAPLUS LOT 31074DK, EXP 01JUL2015
Postal code
60045-4835
Report date
Jul 22, 2015
Product type
Drugs
Recall number
D-1242-2015
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
5,214,900 vials (Hospira label); 250,600 vials (NOVAPLUS label)
Reason for recall
Crystallization; identified as calcium salt of Ketorolac
Voluntary / mandated
Voluntary: Firm initiated
Product description
KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49
Distribution pattern
Nationwide, Puerto Rico, Guam, Canada and Singapore
Recall initiation date
Jun 30, 2015
Initial firm notification
Letter
Center classification date
Jul 15, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1242-2015, published Jul 22, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls